Rocket Pharmaceuticals (RCKT) Shares Outstanding (2014 - 2026)

Rocket Pharmaceuticals has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $109.1 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 2.22% year-over-year to $109.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $109.1 million (up 2.22% YoY) and the FY2025 annual result came in at $108.3 million, up 1.75% from the prior year.
• Shares Outstanding (Entity) rose to $109.1 million in Q1 2026 per RCKT's latest filing, from $108.3 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $109.1 million in Q1 2026 and troughed at $64.5 million in Q1 2022.
• A 5-year average of $90.5 million and a median of $90.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) surged 32.88% in 2023, then grew 1.08% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $79.1 million in 2022, then rose by 14.1% to $90.3 million in 2023, then grew by 17.91% to $106.5 million in 2024, then gained by 1.75% to $108.3 million in 2025, then gained by 0.74% to $109.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $109.1 million, $108.3 million, and $108.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.